Charlotte Lynne Bevan (Charlotte L Bevan, C L Bevan)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 23

Top Topics

Benign Prostatic Hyperplasia

Radical Prostatectomy

Long Noncoding Rna

Top Venues

The Journal of endocrinology

British journal of cancer

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Theodora A Constantin, Anabel Varela-Carver, Kyle K Greenland, Gilberto Serrano de Almeida, Ellen Olden, Lucy Penfold, Simon Ang, Alice Ormrod, Damien A Leach, Chun-Fui Lai, Edward K Ainscow, Ash K Bahl, David Carling, Matthew John Fuchter, Simak Ali, Charlotte Lynne Bevan
Correction: The CDK7 inhibitor CT7001 (Samuraciclib) targets proliferation pathways to inhibit advanced prostate cancer. British journal of cancer (2024)
J N Zamarbide Losada, E Sulpice, S Combe, G S Almeida, Damien A Leach, J Choo, L Protopapa, M P Hamilton, S McGuire, Xavier Gidrol, Charlotte Lynne Bevan, Claire Emily Fletcher
Apoptosis-modulatory miR-361-3p as a novel treatment target in endocrine-responsive and endocrine-resistant breast cancer. The Journal of endocrinology 256 (3) (2023)
Theodora A Constantin, Anabel Varela-Carver, Kyle K Greenland, Gilberto Serrano de Almeida, Ellen Olden, Lucy Penfold, Simon Ang, Alice Ormrod, Damien A Leach, Chun-Fui Lai, Edward K Ainscow, Ash K Bahl, David Carling, Matthew John Fuchter, Simak Ali, Charlotte Lynne Bevan
The CDK7 inhibitor CT7001 (Samuraciclib) targets proliferation pathways to inhibit advanced prostate cancer. British journal of cancer (2023)
J N Zamarbide Losada, E Sulpice, S Combe, G S Almeida, Damien A Leach, J Choo, L Protopapa, M P Hamilton, S McGuire, Xavier Gidrol, Charlotte Lynne Bevan, Claire Emily Fletcher
Apoptosis-modulatory miR-361-3p as a novel treatment target in endocrine-responsive and endocrine-resistant breast cancer. The Journal of endocrinology 256 (3) (2023)
J N Zamarbide Losada, E Sulpice, S Combe, G S Almeida, Damien A Leach, J Choo, L Protopapa, M P Hamilton, S McGuire, Xavier Gidrol, Charlotte Lynne Bevan, Claire Emily Fletcher
Apoptosis-modulatory miR-361-3p as a novel treatment target in endocrine-responsive and endocrine-resistant breast cancer. The Journal of endocrinology 256 (3) (2023)
Claire Emily Fletcher, Molly Ann Taylor, Charlotte Lynne Bevan
PLK1 Regulates MicroRNA Biogenesis through Drosha Phosphorylation. International journal of molecular sciences 24 (18) (2023)
J N Zamarbide Losada, E Sulpice, S Combe, G S Almeida, Damien A Leach, J Choo, L Protopapa, M P Hamilton, S McGuire, Xavier Gidrol, Charlotte Lynne Bevan, Claire Emily Fletcher
Apoptosis-modulatory miR-361-3p as a novel treatment target in endocrine-responsive and endocrine-resistant breast cancer. The Journal of endocrinology 256 (3) (2023)
Damien A Leach, Rayzel C Fernandes, Charlotte Lynne Bevan
Cellular specificity of androgen receptor, coregulators, and pioneer factors in prostate cancer. Endocrine oncology (Bristol, England) 2 (1) (2022)
Folake Orafidiya, Lin Deng, Charlotte Lynne Bevan, Claire Emily Fletcher
Crosstalk between Long Non Coding RNAs, microRNAs and DNA Damage Repair in Prostate Cancer: New Therapeutic Opportunities? Cancers 14 (3) (2022)
Alison K Buxton, Salma Abbasova, Charlotte Lynne Bevan, Damien A Leach
Liver Microenvironment Response to Prostate Cancer Metastasis and Hormonal Therapy. Cancers 14 (24) (2022)
Sharmila Rana, Gabriel N Valbuena, Ed Curry, Charlotte Lynne Bevan, Hector C Keun
MicroRNAs as biomarkers for prostate cancer prognosis: a systematic review and a systematic reanalysis of public data. British journal of cancer 126 (3) (2022)
Joseph Broomfield, Melpomeni Kalofonou, Thomas Pataillot-Meakin, Sue M Powell, Rayzel C Fernandes, Nicolas Moser, Charlotte Lynne Bevan, Pantelis Georgiou
Detection of YAP1 and AR-V7 mRNA for Prostate Cancer Prognosis Using an ISFET Lab-On-Chip Platform. ACS sensors 7 (11) (2022)
Claire Emily Fletcher, L Deng, F Orafidiya, W Yuan, M P G S Lorentzen, O W Cyran, A Varela-Carver, T A Constantin, D A Leach, F M Dobbs, I Figueiredo, B Gurel, E Parkes, D Bogdan, R R Pereira, S G Zhao, A Neeb, F Issa, J Hester, H Kudo, Y Liu, Y Philippou, R Bristow, K Knudsen, R J Bryant, F Y Feng, S H Reed, I G Mills, J de Bono, Charlotte Lynne Bevan
A non-coding RNA balancing act: miR-346-induced DNA damage is limited by the long non-coding RNA NORAD in prostate cancer. Molecular cancer 21 (1) (2022)
Alison K Buxton, Salma Abbasova, Charlotte Lynne Bevan, Damien A Leach
Liver Microenvironment Response to Prostate Cancer Metastasis and Hormonal Therapy. Cancers 14 (24) (2022)
Theodora A Constantin, Kyle K Greenland, Anabel Varela-Carver, Charlotte Lynne Bevan
Transcription associated cyclin-dependent kinases as therapeutic targets for prostate cancer. Oncogene 41 (24) (2022)
Damien A Leach, Greg N Brooke, Charlotte Lynne Bevan
Roles of steroid receptors in the lung and COVID-19. Essays in biochemistry 65 (6) (2021)
Scott Lovell, Leran Zhang, Thomas Kryza, Anna Neodo, Nathalie Bock, Elena De Vita, Elizabeth D Williams, Elisabeth Engelsberger, Congyi Xu, Alexander T Bakker, Marı A Maneiro, Reiko J Tanaka, Charlotte Lynne Bevan, Judith A Clements, Edward William Tate
A Suite of Activity-Based Probes To Dissect the KLK Activome in Drug-Resistant Prostate Cancer. Journal of the American Chemical Society 143 (23) (2021)
D A Leach, A Mohr, Efstathios S Giotis, Emine Cil, A M Isac, L L Yates, Wendy S Barclay, R M Zwacka, Charlotte Lynne Bevan, Greg N Brooke
The antiandrogen enzalutamide downregulates TMPRSS2 and reduces cellular entry of SARS-CoV-2 in human lung cells. Nature communications 12 (1) (2021)
Eva Estébanez-Perpiñá, Charlotte Lynne Bevan, Iain J McEwan
Eighty Years of Targeting Androgen Receptor Activity in Prostate Cancer: The Fight Goes on. Cancers 13 (3) (2021)
Shenglin Cai, Thomas Pataillot-Meakin, Akifumi Shibakawa, Ren Ren, Charlotte Lynne Bevan, Sylvain Ladame, Aleksandar P Ivanov, Joshua B Edel
Single-molecule amplification-free multiplexed detection of circulating microRNA cancer biomarkers from serum. Nature communications 12 (1) (2021)
Charlotte Lynne Bevan
Breaking down walls in prostate cancer with the MURAL collection of patient-derived xenografts. Nature communications 12 (1) (2021)
Sheba Jarvis, Catherine Williamson, Charlotte Lynne Bevan
Liver X Receptors and Male (In)fertility. International journal of molecular sciences 20 (21) (2019)
Dafydd Alwyn Dart, Sahar Kandil, Serena Tommasini-Ghelfi, Gilberto Serrano de Almeida, Charlotte Lynne Bevan, Wenguo Jiang, Andrew D Westwell
Novel Trifluoromethylated Enobosarm Analogues with Potent Antiandrogenic Activity In Vitro and Tissue Selectivity In Vivo. Molecular cancer therapeutics 17 (9) (2018)